Published in J Am Acad Dermatol on May 01, 1996
Clinical characteristics and outcomes of juvenile and adult dermatomyositis. J Korean Med Sci (2009) 0.84
Dermatomyositis: analysis of 109 patients surveyed at the Hospital das Clínicas (HCFMUSP), São Paulo, Brazil. An Bras Dermatol (2014) 0.83
Skeletal muscle major histocompatibility complex class I and II expression differences in adult and juvenile dermatomyositis. Clinics (Sao Paulo) (2012) 0.80
Corticosteroids in Myositis and Scleroderma. Rheum Dis Clin North Am (2015) 0.77
Indications for IVIG in rheumatic diseases. Rheumatology (Oxford) (2014) 0.77
Syndrome in question. An Bras Dermatol (2016) 0.75
Cutaneous Manifestations of Dermatomyositis: a Comprehensive Review. Clin Rev Allergy Immunol (2017) 0.75
Pyoderma gangrenosum. Lancet (1998) 4.87
Damp housing, mould growth, and symptomatic health state. BMJ (1989) 4.56
Autoimmune-associated congenital heart block: demographics, mortality, morbidity and recurrence rates obtained from a national neonatal lupus registry. J Am Coll Cardiol (1998) 3.68
Safety of a new micronized formulation of isotretinoin in patients with severe recalcitrant nodular acne: A randomized trial comparing micronized isotretinoin with standard isotretinoin. J Am Acad Dermatol (2001) 2.80
Amyopathic dermatomyositis (dermatomyositis siné myositis). Presentation of six new cases and review of the literature. J Am Acad Dermatol (1991) 2.53
Subacute cutaneous lupus erythematosus: a cutaneous marker for a distinct lupus erythematosus subset. Arch Dermatol (1979) 2.53
Anti-Ro (SS-A) and anti-La (SS-B) in patients with Sjögren's syndrome. Arthritis Rheum (1986) 2.39
Focal dermal hypoplasia syndrome. A review of the literature and report of two cases. Arch Dermatol (1970) 2.33
Thalidomide for the treatment of chronic graft-versus-host disease. N Engl J Med (1992) 2.31
Subsets in systemic lupus erythematosus. J Invest Dermatol (1979) 2.30
DNA repair and aging in basal cell carcinoma: a molecular epidemiology study. Proc Natl Acad Sci U S A (1993) 2.27
Serological findings in patients with "ANA-negative" systemic lupus erythematosus. Medicine (Baltimore) (1981) 2.27
Serologic and HLA associations in subacute cutaneous lupus erythematosus, a clinical subset of lupus erythematosus. Ann Intern Med (1982) 2.26
Pyoderma gangrenosum. A comparison of typical and atypical forms with an emphasis on time to remission. Case review of 86 patients from 2 institutions. Medicine (Baltimore) (2000) 2.14
Lichenoid chronic graft-vs-host disease occurring in a dermatomal distribution. Arch Dermatol (1994) 2.05
Systemic lupus erythematosus: a review of clinico-laboratory features and immunogenetic markers in 150 patients with emphasis on demographic subsets. Medicine (Baltimore) (1985) 2.01
Immunofluorescent techniques in clinical diagnosis of cutaneous disease. Ann Intern Med (1969) 1.99
Anticentromere and anticentriole antibodies in the scleroderma spectrum. Arch Dermatol (1983) 1.95
Serologic tests for syphilis and the false-positive reactor. Arch Dermatol (1966) 1.95
Fluorescent treponemal-antibody absorption tests. Studies of false-positive reactions to tests for syphilis. N Engl J Med (1967) 1.91
Bullous pemphigoid. Clinical and immunologic follow-up after successful therapy. Arch Dermatol (1977) 1.90
Focal dermal hypoplasia syndrome. An update. Arch Dermatol (1992) 1.88
Predictors of death from chronic graft-versus-host disease after bone marrow transplantation. Blood (1989) 1.85
Reliability testing of the dermatology index of disease severity (DIDS). An index for staging the severity of cutaneous inflammatory disease. Arch Dermatol (1997) 1.81
Ethylenediamine contact dermatitis. Arch Dermatol (1967) 1.80
The utility of submitting fibroepithelial polyps for histological examination. Arch Dermatol (1996) 1.79
Genetic control of transcription during development of phage gamma. Proc Natl Acad Sci U S A (1967) 1.78
The use of cervicography in a primary screening service. Br J Obstet Gynaecol (1991) 1.76
Development and field-test validation of an assay for DNA repair in circulating human lymphocytes. Cancer Res (1991) 1.76
Distinctive cutaneous subsets in the spectrum of lupus erythematosus. J Am Acad Dermatol (1981) 1.76
A double-blind, vehicle-controlled study evaluating masoprocol cream in the treatment of actinic keratoses on the head and neck. J Am Acad Dermatol (1991) 1.75
Evidence for complement activation via the alternate pathway in skin diseases, I. Herpes gestationis, systemic lupus erythematosus, and bullous pemphigoid. J Clin Invest (1973) 1.73
Immunoglobulin binding in cardiomyopathic hearts. Circulation (1971) 1.72
Sjögren's syndrome: association of anti-Ro(SS-A) antibodies with vasculitis, hematologic abnormalities, and serologic hyperreactivity. Ann Intern Med (1983) 1.68
Cutaneous involvement in malignant histiocytosis. Case report and review of the literature. Arch Dermatol (1981) 1.64
International comparisons of preterm birth: higher rates of late preterm birth are associated with lower rates of stillbirth and neonatal death. BJOG (2012) 1.63
Autoimmune response directed against conserved determinants of nuclear envelope proteins in a patient with linear scleroderma. Proc Natl Acad Sci U S A (1983) 1.62
Search for supersymmetry using final states with one lepton, jets, and missing transverse momentum with the ATLAS detector in √s=7 TeV pp collisions. Phys Rev Lett (2011) 1.60
The diagnostic yield of histologic examination of seborrheic keratoses. Arch Dermatol (1997) 1.59
Severe graft-versus-host disease in a liver-transplant recipient. N Engl J Med (1988) 1.59
Vehicle-Related Hydrocarbon Source Compositions from Ambient Data: The GRACE/SAFER Method. Environ Sci Technol (1994) 1.59
Cutaneous leukocytoclastic vasculitis. Clinical and laboratory features of 82 patients seen in private practice. Arch Dermatol (1984) 1.56
Epidermolysis bullosa acquisita: ultrastructural and immunological studies. J Invest Dermatol (1981) 1.55
The value of malignancy evaluation in patients with dermatomyositis. J Am Acad Dermatol (1982) 1.53
The clinical significance of autoantibodies to a soluble cytoplasmic antigen in systemic lupus erythematosus and other connective tissue diseases. J Rheumatol (1979) 1.51
Phase I trial of interferon gamma to potentiate cyclosporine-induced graft-versus-host disease in women undergoing autologous bone marrow transplantation for breast cancer. J Clin Oncol (1994) 1.50
Histopathologic comparison of the subsets of lupus erythematosus. Arch Dermatol (1990) 1.50
Gene interaction at HLA-DQ enhances autoantibody production in primary Sjögren's syndrome. Science (1986) 1.50
Heat shock-mediated cell cycle blockage and G1 cyclin expression in the yeast Saccharomyces cerevisiae. Mol Cell Biol (1993) 1.50
Neonatal lupus erythematosus: new serologic findings. J Invest Dermatol (1981) 1.49
Ketoconazole 2% shampoo in the treatment of tinea versicolor: a multicenter, randomized, double-blind, placebo-controlled trial. J Am Acad Dermatol (1998) 1.49
Influence of age on the response to Streptococcus pneumoniae vaccine in patients with recurrent infections and normal immunoglobulin concentrations. J Allergy Clin Immunol (1998) 1.48
Primary care physicians' errors in handling cutaneous disorders. A prospective survey. J Am Acad Dermatol (1987) 1.48
The use of monoclonal antibody to keratin in human epidermal disease: alterations in immunohistochemical staining pattern. J Invest Dermatol (1983) 1.48
Disperse versus compact elements for the regulation of runt stripes in Drosophila. Dev Biol (1996) 1.48
A molecular defect in loricrin, the major component of the cornified cell envelope, underlies Vohwinkel's syndrome. Nat Genet (1996) 1.47
Twenty percent of biopsy specimens from sun-exposed skin of normal young adults demonstrate positive immunofluorescence. Arch Dermatol (1991) 1.47
Chlorambucil. An effective corticosteroid-sparing agent for patients with recalcitrant dermatomyositis. Arthritis Rheum (1993) 1.47
DNA repair capacity for ultraviolet light-induced damage is reduced in peripheral lymphocytes from patients with basal cell carcinoma. J Invest Dermatol (1995) 1.47
Comparison of the reliability and validity of outcome instruments for cutaneous dermatomyositis. Br J Dermatol (2008) 1.44
High-grade atrioventricular heart block in an adult with systemic lupus erythematosus: the association of nuclear RNP (U1 RNP) antibodies, a case report, and review of the literature. Arthritis Rheum (1989) 1.43
Guidelines of care for warts: human papillomavirus. Committee on Guidelines of Care. J Am Acad Dermatol (1995) 1.43
Early melanoma. Histologic terms. Am J Dermatopathol (1991) 1.43
Effect of mutations in the c2 and c3 genes of bacteriophage lambda on macromolecular synthesis in infected cells. J Mol Biol (1970) 1.42
A systematic review of drug-induced subacute cutaneous lupus erythematosus. Br J Dermatol (2011) 1.42
Observation of a centrality-dependent dijet asymmetry in lead-lead collisions at sqrt[S(NN)] =2.76 TeV with the ATLAS detector at the LHC. Phys Rev Lett (2010) 1.41
Lichen planus associated with neoplasia: a cell-mediated immune response to tumor antigens? J Am Acad Dermatol (1994) 1.41
Reflex sympathetic dystrophy: a review. J Am Acad Dermatol (1990) 1.41
Graft-versus-host disease in cyclosporin A-treated rats after syngeneic and autologous bone marrow reconstitution. J Exp Med (1983) 1.41
Low-dose methotrexate administered weekly is an effective corticosteroid-sparing agent for the treatment of the cutaneous manifestations of dermatomyositis. J Am Acad Dermatol (1997) 1.40
Measurement of dijet azimuthal decorrelations in pp collisions at sqrt(s)=7 TeV. Phys Rev Lett (2011) 1.39
Fixed drug eruption from pamabrom. Cleve Clin J Med (1991) 1.39
American Academy of Dermatology guidelines of care. Development and process. Arch Dermatol (1997) 1.38
The spectrum of Reiter's disease. J Am Acad Dermatol (1979) 1.38
Amyopathic dermatomyositis: a review. J Invest Dermatol (1993) 1.36
Clinical features and treatment of peristomal pyoderma gangrenosum. JAMA (2000) 1.36
Regulation of bacteriophage lambda development by gene N: properties of a mutation that bypasses N control of late protein synthesis. Virology (1970) 1.35
Nodular fasciitis: response to intralesional corticosteroids. J Am Acad Dermatol (1999) 1.35
Metastatic basal cell carcinoma: a clinicopathologic study of seventeen cases. Cancer (1980) 1.34
Determination of the strange-quark density of the proton from ATLAS measurements of the W→ℓν and Z→ℓℓ cross sections. Phys Rev Lett (2012) 1.34
Neurologic complications of primary Sjögren's syndrome. Medicine (Baltimore) (1982) 1.34
The eye in bone marrow transplantation. III. Conjunctival graft-vs-host disease. Arch Ophthalmol (1989) 1.34
Factors influencing enrollment in clinical trials for cancer treatment. South Med J (1999) 1.33
The relationship of dermatomyositis and polymyositis to internal malignancy. Arch Dermatol (1980) 1.33
The immunopathology of herpes gestationis. Immunofluorescence studies and characterization of "HG factor". J Clin Invest (1976) 1.33
Morphological, biochemical, and functional changes in human platelets subjected to shear stress. J Lab Clin Med (1975) 1.33
Design and biological activities of L-163,191 (MK-0677): a potent, orally active growth hormone secretagogue. Proc Natl Acad Sci U S A (1995) 1.32
Molecular characterization of human Ro/SS-A antigen. Amino terminal sequence of the protein moiety of human Ro/SS-A antigen and immunological activity of a corresponding synthetic peptide. J Clin Invest (1988) 1.32
Search for new particles in two-jet final states in 7 TeV proton-proton collisions with the ATLAS detector at the LHC. Phys Rev Lett (2010) 1.32
Neonatal lupus erythematosus. A clinical, serological and immunogenetic study with review of the literature. Medicine (Baltimore) (1984) 1.30
Skin changes secondary to hydroxyurea therapy. Arch Dermatol (1975) 1.29
The redistribution of a conserved nuclear envelope protein during the cell cycle suggests a pathway for chromosome condensation. Cell (1984) 1.29
Study of cutaneous lupus erythematosus by immunohistochemical methods. Arch Dermatol (1968) 1.29
Cutis laxa. A manifestation of generalized elastolysis. Arch Dermatol (1965) 1.28
Vasculitis in granuloma annulare: histopathology and direct immunofluorescence. Arch Dermatol (1977) 1.28